Search research articles
Contact Us
Filters
Showing results (1-10 of 148) with videos related to
Page
of 15
Sort By:
Drug News & Perspectives
|
February 12, 2009
Asparagine synthetase: a new potential biomarker in ovarian cancer
Philip L Lorenzi, John N Weinstein
Nature
|
November 29, 2013
Cancer: Discrepancies in drug sensitivity
John N Weinstein, Philip L Lorenzi
Blood
|
August 17, 2019
Amino acid metabolism in hematologic malignancies and the era of targeted therapy
Yoko Tabe, Philip L Lorenzi, Marina Konopleva
Journal of the American Society for Mass Spectrometry
|
October 9, 2023
Quantitative Analysis of Acetyl-CoA, Malonyl-CoA, and Succinyl-CoA in Myocytes
Lin Tan, Sara A Martinez, Philip L Lorenzi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 15, 2005
Nucleoside ester prodrug substrate specificity of liver carboxylesterase
Christopher P Landowski, Philip L Lorenzi, Xueqin Song, et al.
Autophagy
|
June 7, 2014
A curated census of autophagy-modulating proteins and small molecules: candidate targets for cancer therapy
Philip L Lorenzi, Sofie Claerhout, Gordon B Mills, et al.
Drugs of the Future
|
November 25, 2014
MODULATION OF AUTOPHAGY AND ITS POTENTIAL FOR CANCER THERAPY
Sofie Claerhout, Philip L Lorenzi, John N Weinstein, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 4, 2017
Positional stable isotope tracer analysis reveals carbon routes during ammonia metabolism of <i>Aedes aegypti</i> mosquitoes
Thomas D Horvath, Shai Dagan, Philip L Lorenzi, et al.
Nature Communications
|
January 30, 2026
Supercharging-enhanced nDIA-MS enables global profiling of drug-induced proteome solubility shifts
Yun Xiong, Huimin Zhang, Lin Tan, et al.
Pharmaceutical Research
|
September 1, 2005
Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism
Christopher P Landowski, Xueqin Song, Philip L Lorenzi, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 148) with videos related to
Sort By:
Page
of 15
Drug News & Perspectives
|
February 12, 2009
Asparagine synthetase: a new potential biomarker in ovarian cancer
Philip L Lorenzi, John N Weinstein
Nature
|
November 29, 2013
Cancer: Discrepancies in drug sensitivity
John N Weinstein, Philip L Lorenzi
Blood
|
August 17, 2019
Amino acid metabolism in hematologic malignancies and the era of targeted therapy
Yoko Tabe, Philip L Lorenzi, Marina Konopleva
Journal of the American Society for Mass Spectrometry
|
October 9, 2023
Quantitative Analysis of Acetyl-CoA, Malonyl-CoA, and Succinyl-CoA in Myocytes
Lin Tan, Sara A Martinez, Philip L Lorenzi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 15, 2005
Nucleoside ester prodrug substrate specificity of liver carboxylesterase
Christopher P Landowski, Philip L Lorenzi, Xueqin Song, et al.
Autophagy
|
June 7, 2014
A curated census of autophagy-modulating proteins and small molecules: candidate targets for cancer therapy
Philip L Lorenzi, Sofie Claerhout, Gordon B Mills, et al.
Drugs of the Future
|
November 25, 2014
MODULATION OF AUTOPHAGY AND ITS POTENTIAL FOR CANCER THERAPY
Sofie Claerhout, Philip L Lorenzi, John N Weinstein, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 4, 2017
Positional stable isotope tracer analysis reveals carbon routes during ammonia metabolism of <i>Aedes aegypti</i> mosquitoes
Thomas D Horvath, Shai Dagan, Philip L Lorenzi, et al.
Nature Communications
|
January 30, 2026
Supercharging-enhanced nDIA-MS enables global profiling of drug-induced proteome solubility shifts
Yun Xiong, Huimin Zhang, Lin Tan, et al.
Pharmaceutical Research
|
September 1, 2005
Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism
Christopher P Landowski, Xueqin Song, Philip L Lorenzi, et al.
Page
of 15